Dr. Oğuz Mülazımoğlu Appointed as New General Manager of Nobel İlaç
With 100% domestic capital, Nobel İlaç, which has led the development and international expansion of the Turkish pharmaceutical industry for more than 70 years, has appointed Dr. Oğuz Mülazımoğlu to the position of General Manager.
Nobel İlaç, a 100 percent domestically-owned pharmaceutical company that has pioneered the development and international expansion of the Turkish pharmaceutical sector for over 70 years, has appointed Dr. Oğuz Mülazımoğlu as General Manager.
In line with its "Value for Health" vision, Nobel İlaç aims to advance its deep-rooted heritage and corporate structure further, leveraging Dr. Mülazımoğlu's more than 30 years of experience in the sector to continue its growth both domestically and internationally.
First Statement from Dr. Oğuz Mülazımoğlu
In his comments on the appointment, Nobel İlaç's new General Manager Dr. Oğuz Mülazımoğlu said: "I am honored and proud to take on the role of General Manager at Nobel İlaç. For me, this responsibility represents both a great privilege and significant duty at Nobel İlaç, one of the sector's leading organizations with its deep-rooted heritage, strong values and international vision. With the support of our Board of Directors and the commitment of our employees, we aim to continue sustainable growth by advancing our 'Value for Health' understanding further and increasing our contributions to making pharmaceuticals more accessible for human health. Together with my team colleagues, we will pursue our efforts with full vigor to carry forward Nobel İlaç's deep-rooted and accomplished legacy into the future."
About Dr. Oğuz Mülazımoğlu
Dr. Oğuz Mülazımoğlu is a graduate of Istanbul University Faculty of Medicine Çapa. He completed an Executive MBA at Boğaziçi University and a master's degree program in Hospital Management at Istanbul University.
Mülazımoğlu began his career in 1992 as Product Manager at Knoll Germany, and later served as Global Product Manager responsible for 35 countries at the company's German headquarters. After returning to Turkey, he held the positions of Assistant General Manager at Knoll Germany and, following the Abbott-Knoll merger, National Sales Manager at Abbott.
He subsequently served as General Manager for Central Asia at Schering-Plough, Director of General Medicine and Women's Health at Bayer Turkey, and Regional Marketing Director for General Medicine and Women's Health in the EMEA region based in Berlin.
Mülazımoğlu was appointed Country Manager at Bayer Pharma Turkey in 2015 and served as General Manager responsible for Prescription Products Sales and Marketing at Abdi İbrahim İlaç in 2018. In 2023, he left Abdi İbrahim and founded Esta Farma Ltd., while assuming the representation of US-based L-Nutra in Turkey and bringing the innovative nutrition product ProLon to the Turkish market.
Dr. Mülazımoğlu is an ICF-certified Erickson coach and speaks English and German.
Gallery
